All drugs from this manufacturer
The drug is indicated for the treatment of chronic hepatitis C in adults, adolescents, and children aged 3 years and older. It should be used only in combination with interferon alfa-2b or peginterferon alfa-2b.
Dosage form: capsules
ATC: J05AB04